CDX-3379
Product Specifications
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, JAK/STAT signaling
Bioactivity
CDX-3379 is a humanized monoclonal antibody inhibitor that targets ErbB3. By binding to ErbB3, CDX-3379 prevents its dimerization with other receptors, thus inhibiting ErbB3 phosphorylation. This compound can also inhibit the growth and proliferation of tumor cells. CDX-3379 shows potential for research in tumors expressing ErbB3 and NRG1, such as those found in HNSCC.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog